Differentiation of Tumor Progression from Pseudoprogression in Patients with Posttreatment Glioblastoma Using Multiparametric Histogram Analysis

The Role of Preload and Leakage Correction in Gadolinium-Based Cerebral Blood Volume Estimation Determined by Comparison with MION as a Criterion Standard

(2012) J. L. Boxerman et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Analysis of the layering pattern of the apparent diffusion coefficient (ADC) for differentiation of radiation necrosis from tumour progression

(2012) Jihoon Cha et al.   EUROPEAN RADIOLOGY

Imaging modalities in high-grade gliomas: Pseudoprogression, recurrence, or necrosis?

(2012) I. Caroline et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival

(2012) L. S. Hu et al.   NEURO-ONCOLOGY

Percent Change of Perfusion Skewness and Kurtosis: A Potential Imaging Biomarker for Early Treatment Response in Patients with Newly Diagnosed Glioblastomas

(2012) Hye Jin Baek et al.   RADIOLOGY

Double reading of radiological examinations in Norway

(2011) Jenny A Husby et al.   ACTA RADIOLOGICA

Diagnostic Dilemma of Pseudoprogression in the Treatment of Newly Diagnosed Glioblastomas: The Role of Assessing Relative Cerebral Blood Flow Volume and Oxygen-6-Methylguanine-DNA Methyltransferase Promoter Methylation Status

(2011) D.-S. Kong et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Pseudoprogression and Pseudoresponse: Imaging Challenges in the Assessment of Posttreatment Glioma

(2011) L.C. Hygino da Cruz et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group

(2010) Patrick Y. Wen et al.   JOURNAL OF CLINICAL ONCOLOGY

Changes in Relative Cerebral Blood Volume 1 Month after Radiation-Temozolomide Therapy Can Help Predict Overall Survival in Patients with Glioblastoma

(2010) Rajiv Mangla et al.   RADIOLOGY

Posttreatment High-Grade Glioma: Usefulness of Peak Height Position with Semiquantitative MR Perfusion Histogram Analysis in an Entire Contrast-enhanced Lesion for Predicting Volume Fraction of Recurrence

(2010) Ho Sung Kim et al.   RADIOLOGY

New advances that enable identification of glioblastoma recurrence

(2009) Isaac Yang et al.   Nature Reviews Clinical Oncology

Pseudoprogression after radiotherapy with concurrent temozolomide for high-grade glioma: clinical observations and working recommendations

(2009) Cristo Chaskis et al.   SURGICAL NEUROLOGY

Pathological review of late cerebral radionecrosis

(2008) Yoshihiko Yoshii   Brain Tumor Pathology

Incidence of early pseudo‐progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide

(2008) Walter Taal et al.   CANCER

Pseudoprogression in Glioblastoma

(2008) Marc C. Chamberlain   JOURNAL OF CLINICAL ONCOLOGY

MGMTPromoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients

(2008) Alba A. Brandes et al.   JOURNAL OF CLINICAL ONCOLOGY

Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas

(2008) Dieta Brandsma et al.   LANCET ONCOLOGY

Glioma Grading by Using Histogram Analysis of Blood Volume Heterogeneity from MR-derived Cerebral Blood Volume Maps

(2008) Kyrre E. Emblem et al.   RADIOLOGY